1-3 of 3
John Roy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Michael D. Tarantino, MD, Jenny M. Despotovic, DO, MS, John Roy, John Grainger, MD MRCP, FRPATH, Nichola Cooper, MRCP, Donald Beam, Ashok Raj, Alexey A. Maschan, MD, June Kim, PhD, Melissa Jeanne Eisen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2428.
https://doi.org/10.1182/blood-2018-99-109763
Published: 2018
Journal Articles

Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Michael Tarantino, James B. Bussel, MD, Victor S. Blanchette, MD, Donald Beam, John Roy, Jenny M. Despotovic, DO, MS, Ashok Raj, Nancy Carpenter, Bhakti Mehta, Melissa Eisen
Journal: Blood
Blood (2017) 130 (Supplement 1): 14.
https://doi.org/10.1182/blood.V130.Suppl_1.14.14
Published: 2017
Journal Articles

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

James B. Bussel, MD, Michael D. Tarantino, Victor S. Blanchette, Ashok Raj, Jenny Despotovic, Donald Beam, John Roy, Xuena Wang, Bhakti Mehta, Melissa Eisen
Journal: Blood
Blood (2016) 128 (22): 3738.
https://doi.org/10.1182/blood.V128.22.3738.3738
Published: 2016